These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33132380)

  • 1. Improvement of Pharmaceutical Properties of Zerumbone, a Multifunctional Compound, Using Cyclodextrin Derivatives.
    Hassan MM; Mohammed AFA; Elamin KM; Devkota HP; Ohno Y; Motoyama K; Higashi T; Imai T
    Chem Pharm Bull (Tokyo); 2020; 68(11):1117-1120. PubMed ID: 33132380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stabilizing and solubilizing effects of sulfobutyl ether beta-cyclodextrin on prostaglandin E1 analogue.
    Uekama K; Hieda Y; Hirayama F; Arima H; Sudoh M; Yagi A; Terashima H
    Pharm Res; 2001 Nov; 18(11):1578-85. PubMed ID: 11758766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of some pharmaceutical properties of DY-9760e by sulfobutyl ether beta-cyclodextrin.
    Nagase Y; Hirata M; Wada K; Arima H; Hirayama F; Irie T; Kikuchi M; Uekama K
    Int J Pharm; 2001 Oct; 229(1-2):163-72. PubMed ID: 11604269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of solubility and oral bioavailability of rutin by complexation with 2-hydroxypropyl-beta-cyclodextrin.
    Miyake K; Arima H; Hirayama F; Yamamoto M; Horikawa T; Sumiyoshi H; Noda S; Uekama K
    Pharm Dev Technol; 2000; 5(3):399-407. PubMed ID: 10934740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental, molecular docking investigations and bioavailability study on the inclusion complexes of finasteride and cyclodextrins.
    Mady FM; Farghaly Aly U
    Drug Des Devel Ther; 2017; 11():1681-1692. PubMed ID: 28652706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative studies of the enhancing effects of cyclodextrins on the solubility and oral bioavailability of tacrolimus in rats.
    Arima H; Yunomae K; Miyake K; Irie T; Hirayama F; Uekama K
    J Pharm Sci; 2001 Jun; 90(6):690-701. PubMed ID: 11357172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of parenteral formulation for a novel angiogenesis inhibitor, CKD-732 through complexation with hydroxypropyl-beta-cyclodextrin.
    Kim JH; Lee SK; Ki MH; Choi WK; Ahn SK; Shin HJ; Hong CI
    Int J Pharm; 2004 Mar; 272(1-2):79-89. PubMed ID: 15019071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inclusion complexation of artemisinin with alpha-, beta-, and gamma-cyclodextrins.
    Wong JW; Yuen KH
    Drug Dev Ind Pharm; 2003 Oct; 29(9):1035-44. PubMed ID: 14606667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bicalutamide Anticancer Activity Enhancement by Formulation of Soluble Inclusion Complexes with Cyclodextrins.
    De Gaetano F; Cristiano MC; Paolino D; Celesti C; Iannazzo D; Pistarà V; Iraci N; Ventura CA
    Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36421730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Encapsulation and Stabilization of α-Lipoic Acid in Cyclodextrin Inclusion Complex Electrospun Nanofibers: Antioxidant and Fast-Dissolving α-Lipoic Acid/Cyclodextrin Nanofibrous Webs.
    Celebioglu A; Uyar T
    J Agric Food Chem; 2019 Nov; 67(47):13093-13107. PubMed ID: 31693349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of solubility and oral bioavailability of 2-(N-cyanoimino)-5-[(E)-4-styrylbenzylidene]-4-oxothiazolidine (FPFS-410) with antidiabetic and lipid-lowering activities in dogs by 2-hydroxypropyl-beta-cyclodextrin.
    Hara T; Hirayama F; Arima H; Yamaguchi Y; Uekama K
    Chem Pharm Bull (Tokyo); 2006 Mar; 54(3):344-9. PubMed ID: 16508189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The formation of an inclusion complex between a metabolite of ginsenoside, compound K and γ-cyclodextrin and its dissolution characteristics.
    Igami K; Ozawa M; Inoue S; Iohara D; Miyazaki T; Shinoda M; Anraku M; Hirayama F; Uekama K
    J Pharm Pharmacol; 2016 May; 68(5):646-54. PubMed ID: 26255976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation and biological evaluation of glimepiride-cyclodextrin-polymer systems.
    Ammar HO; Salama HA; Ghorab M; Mahmoud AA
    Int J Pharm; 2006 Feb; 309(1-2):129-38. PubMed ID: 16377107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of the aqueous solubility and masking the bitter taste of famotidine using drug/SBE-beta-CyD/povidone K30 complexation approach.
    Mady FM; Abou-Taleb AE; Khaled KA; Yamasaki K; Iohara D; Ishiguro T; Hirayama F; Uekama K; Otagiri M
    J Pharm Sci; 2010 Oct; 99(10):4285-94. PubMed ID: 20737636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclodextrins: Efficient biocompatible solubilizing excipients for bromhexine liquid and semi-solid drug delivery systems.
    Stojanov M; Nielsen HM; Larsen KL
    Int J Pharm; 2012 Jan; 422(1-2):349-55. PubMed ID: 22027391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cyclodextrins on the solubility and stability of candesartan cilexetil in solution and solid state.
    Al Omari AA; Al Omari MM; Badwan AA; Al-Sou'od KA
    J Pharm Biomed Anal; 2011 Feb; 54(3):503-9. PubMed ID: 20971593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative evaluation of the effect of cyclodextrins and pH on aqueous solubility of apigenin.
    Pápay ZE; Sebestyén Z; Ludányi K; Kállai N; Balogh E; Kósa A; Somavarapu S; Böddi B; Antal I
    J Pharm Biomed Anal; 2016 Jan; 117():210-6. PubMed ID: 26363816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of 2-hydroxypropyl-beta-cyclodextrin in an intramuscular injectable preparation of nimodipine.
    Yoshida A; Yamamoto M; Itoh T; Irie T; Hirayama F; Uekama K
    Chem Pharm Bull (Tokyo); 1990 Jan; 38(1):176-9. PubMed ID: 2337940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study on inclusion complexation of maltosyl-beta-cyclodextrin, heptakis(2,6-di-O-methyl)-beta-cyclodextrin and beta-cyclodextrin with fucosterol in aqueous and solid state.
    Acartürk F; Imai T; Saito H; Ishikawa M; Otagiri M
    J Pharm Pharmacol; 1993 Dec; 45(12):1028-32. PubMed ID: 7908969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some pharmaceutical properties of 3-hydroxypropyl- and 2,3-dihydroxypropyl-beta-cyclodextrins and their solubilizing and stabilizing abilities.
    Yoshida A; Yamamoto M; Irie T; Hirayama F; Uekama K
    Chem Pharm Bull (Tokyo); 1989 Apr; 37(4):1059-63. PubMed ID: 2766408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.